Use of menopausal hormone therapy and bioidentical hormone therapy in Australian women 50 to 69 years of age: Results from a national, cross-sectional study

10.1371/journal.pone.0146494

Saved in:

Bibliographic Details
Main Authors:	Velentzis L.S., Banks E., Sitas F., Salagame U., Tan E.H., Canfell K.
Other Authors:	DEAN'S OFFICE (SSH SCH OF PUBLIC HEALTH)
Format:	Article
Published:	2019
Subjects:	estrogen gestagen plant medicinal product tibolone adult aged Article Australian cross-sectional study female health survey herbal medicine hormonal therapy human hysterectomy major clinical study medicare menopausal syndrome middle aged postmenopause prevalence treatment duration treatment outcome Australia drug effects hormone substitution menopause procedures questionnaire risk factor Aged Cross-Sectional Studies Estrogens Female Health Surveys Hormone Replacement Therapy Humans Menopause Middle Aged Postmenopause Prevalence Risk Factors Surveys and Questionnaires
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/161584
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-161584
record_format	dspace
spelling	sg-nus-scholar.10635-1615842024-11-08T22:43:15Z Use of menopausal hormone therapy and bioidentical hormone therapy in Australian women 50 to 69 years of age: Results from a national, cross-sectional study Velentzis L.S. Banks E. Sitas F. Salagame U. Tan E.H. Canfell K. DEAN'S OFFICE (SSH SCH OF PUBLIC HEALTH) SAW SWEE HOCK SCHOOL OF PUBLIC HEALTH estrogen gestagen plant medicinal product tibolone estrogen adult aged Article Australian cross-sectional study female health survey herbal medicine hormonal therapy human hysterectomy major clinical study medicare menopausal syndrome middle aged postmenopause prevalence treatment duration treatment outcome Australia drug effects hormone substitution menopause procedures questionnaire risk factor Aged Australia Cross-Sectional Studies Estrogens Female Health Surveys Hormone Replacement Therapy Humans Menopause Middle Aged Postmenopause Prevalence Risk Factors Surveys and Questionnaires 10.1371/journal.pone.0146494 PLoS ONE 11 3 e0146494 2019-11-06T08:00:10Z 2019-11-06T08:00:10Z 2016 Article Velentzis L.S., Banks E., Sitas F., Salagame U., Tan E.H., Canfell K. (2016). Use of menopausal hormone therapy and bioidentical hormone therapy in Australian women 50 to 69 years of age: Results from a national, cross-sectional study. PLoS ONE 11 (3) : e0146494. ScholarBank@NUS Repository. https://doi.org/10.1371/journal.pone.0146494 19326203 https://scholarbank.nus.edu.sg/handle/10635/161584 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Unpaywall 20191101
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	estrogen gestagen plant medicinal product tibolone estrogen adult aged Article Australian cross-sectional study female health survey herbal medicine hormonal therapy human hysterectomy major clinical study medicare menopausal syndrome middle aged postmenopause prevalence treatment duration treatment outcome Australia drug effects hormone substitution menopause procedures questionnaire risk factor Aged Australia Cross-Sectional Studies Estrogens Female Health Surveys Hormone Replacement Therapy Humans Menopause Middle Aged Postmenopause Prevalence Risk Factors Surveys and Questionnaires
spellingShingle	estrogen gestagen plant medicinal product tibolone estrogen adult aged Article Australian cross-sectional study female health survey herbal medicine hormonal therapy human hysterectomy major clinical study medicare menopausal syndrome middle aged postmenopause prevalence treatment duration treatment outcome Australia drug effects hormone substitution menopause procedures questionnaire risk factor Aged Australia Cross-Sectional Studies Estrogens Female Health Surveys Hormone Replacement Therapy Humans Menopause Middle Aged Postmenopause Prevalence Risk Factors Surveys and Questionnaires Velentzis L.S. Banks E. Sitas F. Salagame U. Tan E.H. Canfell K. Use of menopausal hormone therapy and bioidentical hormone therapy in Australian women 50 to 69 years of age: Results from a national, cross-sectional study
description	10.1371/journal.pone.0146494
author2	DEAN'S OFFICE (SSH SCH OF PUBLIC HEALTH)
author_facet	DEAN'S OFFICE (SSH SCH OF PUBLIC HEALTH) Velentzis L.S. Banks E. Sitas F. Salagame U. Tan E.H. Canfell K.
format	Article
author	Velentzis L.S. Banks E. Sitas F. Salagame U. Tan E.H. Canfell K.
author_sort	Velentzis L.S.
title	Use of menopausal hormone therapy and bioidentical hormone therapy in Australian women 50 to 69 years of age: Results from a national, cross-sectional study
title_short	Use of menopausal hormone therapy and bioidentical hormone therapy in Australian women 50 to 69 years of age: Results from a national, cross-sectional study
title_full	Use of menopausal hormone therapy and bioidentical hormone therapy in Australian women 50 to 69 years of age: Results from a national, cross-sectional study
title_fullStr	Use of menopausal hormone therapy and bioidentical hormone therapy in Australian women 50 to 69 years of age: Results from a national, cross-sectional study
title_full_unstemmed	Use of menopausal hormone therapy and bioidentical hormone therapy in Australian women 50 to 69 years of age: Results from a national, cross-sectional study
title_sort	use of menopausal hormone therapy and bioidentical hormone therapy in australian women 50 to 69 years of age: results from a national, cross-sectional study
publishDate	2019
url	https://scholarbank.nus.edu.sg/handle/10635/161584
_version_	1821203396288315392

Use of menopausal hormone therapy and bioidentical hormone therapy in Australian women 50 to 69 years of age: Results from a national, cross-sectional study

Similar Items